Corvus Pharmaceuticals Stock Probability of Future Stock Price Finishing Over 7.21

CRVS Stock  USD 8.25  0.84  9.24%   
Corvus Pharmaceuticals' future price is the expected price of Corvus Pharmaceuticals instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Corvus Pharmaceuticals performance during a given time horizon utilizing its historical volatility. Check out Corvus Pharmaceuticals Backtesting, Corvus Pharmaceuticals Valuation, Corvus Pharmaceuticals Correlation, Corvus Pharmaceuticals Hype Analysis, Corvus Pharmaceuticals Volatility, Corvus Pharmaceuticals History as well as Corvus Pharmaceuticals Performance.
For more information on how to buy Corvus Stock please use our How to Invest in Corvus Pharmaceuticals guide.
  
Please specify Corvus Pharmaceuticals' target price for which you would like Corvus Pharmaceuticals odds to be computed.

Corvus Pharmaceuticals Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Corvus Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Corvus Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Corvus Pharmaceuticals appears to be risky and price may revert if volatility continues
Net Loss for the year was (27.03 M) with profit before overhead, payroll, taxes, and interest of 0.
Corvus Pharmaceuticals currently holds about 56.72 M in cash with (23.93 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.22.
Corvus Pharmaceuticals has a frail financial position based on the latest SEC disclosures

Corvus Pharmaceuticals Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Corvus Stock often depends not only on the future outlook of the current and potential Corvus Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Corvus Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding48 M
Cash And Short Term Investments27.1 M

Corvus Pharmaceuticals Technical Analysis

Corvus Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Corvus Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Corvus Pharmaceuticals. In general, you should focus on analyzing Corvus Stock price patterns and their correlations with different microeconomic environments and drivers.

Corvus Pharmaceuticals Predictive Forecast Models

Corvus Pharmaceuticals' time-series forecasting models is one of many Corvus Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Corvus Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Corvus Pharmaceuticals

Checking the ongoing alerts about Corvus Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Corvus Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Corvus Pharmaceuticals appears to be risky and price may revert if volatility continues
Net Loss for the year was (27.03 M) with profit before overhead, payroll, taxes, and interest of 0.
Corvus Pharmaceuticals currently holds about 56.72 M in cash with (23.93 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.22.
Corvus Pharmaceuticals has a frail financial position based on the latest SEC disclosures

Additional Tools for Corvus Stock Analysis

When running Corvus Pharmaceuticals' price analysis, check to measure Corvus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Corvus Pharmaceuticals is operating at the current time. Most of Corvus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Corvus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Corvus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Corvus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.